Back
Tarsus Pharmaceuticals Stock Price Chart
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.
Buy
84
TARS
Tarsus Pharmaceuticals
Last Price:
44.62
Seasonality Move:
37.14%
7 Day Trial
ALL ACCESS PASS
$
7
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TARS is experiencing slight buying pressure.
Tarsus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.99 | Buy |
| 20-day SMA: | 36.38 | Buy |
| 50-day SMA: | 32.55 | Buy |
| 200-day SMA: | 31.38 | Buy |
| 8-day EMA: | 39.54 | Buy |
| 20-day EMA: | 37.06 | Buy |
| 50-day EMA: | 33.8 | Buy |
| 200-day EMA: | 29.61 | Buy |
Tarsus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.37 | Buy |
| Relative Strength Index (14 RSI): | 82.05 | Buy |
| Chaikin Money Flow: | 810403 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.7 - 38.62) | Buy |
| Bollinger Bands (100): | (25.43 - 34.39) | Buy |
Tarsus Pharmaceuticals Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Tarsus Pharmaceuticals Stock
Is Tarsus Pharmaceuticals Stock a Buy?
- Tarsus Pharmaceuticals share price is 43.87 while TARS 8-day simple moving average is 38.99, which is a Buy signal.
- The stock price of TARS is 43.87 while Tarsus Pharmaceuticals 20-day SMA is 36.38, which makes it a Buy.
- Tarsus Pharmaceuticals 50-day simple moving average is 32.55 while TARS share price is 43.87, making it a Buy technically.
- TARS stock price is 43.87 and Tarsus Pharmaceuticals 200-day simple moving average is 31.38, creating a Buy signal.
TARS Technical Analysis vs Fundamental Analysis
Buy
84
Tarsus Pharmaceuticals (TARS)
is a Buy
Is Tarsus Pharmaceuticals a Buy or a Sell?
-
Tarsus Pharmaceuticals stock is rated a Buy
The current Tarsus Pharmaceuticals [TARS] share price is $43.87. The Score for TARS is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
Tarsus Pharmaceuticals Stock Info
Market Cap:
1.67B
Price in USD:
43.87
Share Volume:
2.97M
Tarsus Pharmaceuticals 52-Week Range
52-Week High:
46.71
52-Week Low:
13.90
Buy
84
Tarsus Pharmaceuticals (TARS)
is a Buy
Tarsus Pharmaceuticals Share Price Forecast
-
What is the Tarsus Pharmaceuticals stock price today?
The Tarsus Pharmaceuticals stock price is 43.87 USD today. -
Will TARS stock go up or go down?
Tarsus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Tarsus Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Tarsus Pharmaceuticals is not overvalued.
Is Tarsus Pharmaceuticals Stock a Buy?
- Tarsus Pharmaceuticals share price is 43.87 while TARS 8-day exponential moving average is 39.54, which is a Buy signal.
- The stock price of TARS is 43.87 while Tarsus Pharmaceuticals 20-day EMA is 37.06, which makes it a Buy.
- Tarsus Pharmaceuticals 50-day exponential moving average is 33.80 while TARS share price is 43.87, making it a Buy technically.
- TARS stock price is 43.87 and Tarsus Pharmaceuticals 200-day simple moving average is 29.61, creating a Buy signal.
Fundamental Analysis of Tarsus Pharmaceuticals
Is Tarsus Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.84 per share, and an increase next year of $0.67 per share.
Technical Analysis of Tarsus Pharmaceuticals
Should I short Tarsus Pharmaceuticals stock?
- TARS Moving Average Covergence Divergence (MACD) indicator is 2.37, suggesting Tarsus Pharmaceuticals is a Buy
- Tarsus Pharmaceuticals Relative Strength Index (RSI) is 82.05, which suggest Tarsus Pharmaceuticals is overbought
- The Bollinger Bands (25) for Tarsus Pharmaceuticals is (32.7 - 38.62), which suggest Tarsus Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Tarsus Pharmaceuticals is (25.43 - 34.39), which suggest Tarsus Pharmaceuticals is a Buy
* Tarsus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.